Kalaris Therapeutics, Inc. (KLRS) — Long-term Investment Intensity

Latest as of March 2026: 7.0%

Kalaris Therapeutics, Inc. (KLRS) has a Long-term Investment Intensity of 7.0% as of March 2026. Long-term investments of $7.65 Million represent 7.0% of total assets of $109.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Also explore Kalaris Therapeutics, Inc. balance sheet assets for the complete picture of this company's asset base.

LT Investment Intensity

7.0%
LT Investments / Total Assets

Long-term Investments

$7.65 Million
USD

Total Assets

$109.81 Million
USD

Country

USA
NASDAQ

Annual Long-term Investment Intensity for Kalaris Therapeutics, Inc. (None–None)

The table below presents the year-by-year Long-term Investment Intensity for Kalaris Therapeutics, Inc. from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of Kalaris Therapeutics, Inc..

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
pp = percentage points